Back to Search
LESLIE CITROME, MD, MPH
MD, MPH
Psychiatry Physician
NPI: 1780796045Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
170947(NY)25MA04780900(NJ)
Research & Publications (20)
Effect of ziprasidone dose on all-cause discontinuation rates in acute schizophrenia and schizoaffective disorder: a post-hoc analysis of 4 fixed-dose randomized clinical trials.
PMID 19375893·Schizophr Res·2009
2-rct
Olanzapine plasma concentrations after treatment with 10, 20, and 40 mg/d in patients with schizophrenia: an analysis of correlations with efficacy, weight gain, and prolactin concentration.
PMID 19440083·J Clin Psychopharmacol·2009
8-other
Adding lithium or anticonvulsants to antipsychotics for the treatment of schizophrenia: useful strategy or exercise in futility?
PMID 19573487·J Clin Psychiatry·2009
6-review
Dose trends for second-generation antipsychotic treatment of schizophrenia and bipolar disorder.
PMID 19106035·Schizophr Res·2009
8-other
Olanzapine dosing above the licensed range is more efficacious than lower doses: fact or fiction?
PMID 19589053·Expert Rev Neurother·2009
6-review
Using oral ziprasidone effectively: the food effect and dose-response.
PMID 19669631·Adv Ther·2009
6-review
Iloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second-generation antipsychotic.
PMID 19624791·Int J Clin Pract·2009
1-meta
Teaching the philosophy and tools of evidence-based medicine: misunderstandings and solutions.
PMID 19222621·Int J Clin Pract·2009
8-other
Quantifying risk: the role of absolute and relative measures in interpreting risk of adverse reactions from product labels of antipsychotic medications.
PMID 19534647·Curr Drug Saf·2009
6-review
Olanzapine pamoate: a stick in time? A review of the efficacy and safety profile of a new depot formulation of a second-generation antipsychotic.
PMID 18834452·Int J Clin Pract·2009
6-review
Antipsychotics for the treatment of schizophrenia: likelihood to be helped or harmed, understanding proximal and distal benefits and risks.
PMID 18590478·Expert Rev Neurother·2008
6-review
Schizophrenia, obesity, and antipsychotic medications: what can we do?
PMID 18654065·Postgrad Med·2008
6-review
Public-academic partnerships: integrating state psychiatric hospital treatment and clinical research.
PMID 18757586·Psychiatr Serv·2008
8-other
Compelling or irrelevant? Using number needed to treat can help decide.
PMID 18479317·Acta Psychiatr Scand·2008
4-observational
Current guidelines and their recommendations for prolactin monitoring in psychosis.
PMID 18477625·J Psychopharmacol·2008
6-review
Interpreting and applying the EUFEST results using number needed to treat: antipsychotic effectiveness in first-episode schizophrenia.
PMID 18412940·Int J Clin Pract·2008
8-other
Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics.
PMID 17785613·Ann Pharmacother·2007
6-review
Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety.
PMID 18162018·J Clin Psychiatry·2007
4-observational
Pharmacokinetics of aripiprazole and concomitant carbamazepine.
PMID 17502775·J Clin Psychopharmacol·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11 MEDICAL PARK DR, SUITE 106
POMONA, NY 10970 - Phone
- (845) 398-5595
Quick Facts
- NPI
- 1780796045
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile